ArticleCancers2019

Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy.

Oronzo Brunetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.